Merck Mevacor Pediatric Exclusivity Gets July 3 Hearing; 5 Generics Stayed
The D.C. federal court is scheduled to hear arguments on Merck's Mevacor pediatric exclusivity application July 3.
The D.C. federal court is scheduled to hear arguments on Merck's Mevacor pediatric exclusivity application July 3.